Janus Henderson Group PLC Sells 26,037 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Janus Henderson Group PLC reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 663,902 shares of the medical equipment provider's stock after selling 26,037 shares during the quarter. Janus Henderson Group PLC owned 0.19% of Intuitive Surgical worth $346,535,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $82,517,000. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. raised its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Finally, Czech National Bank lifted its holdings in shares of Intuitive Surgical by 6.9% during the 4th quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock valued at $40,309,000 after buying an additional 4,970 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Royal Bank of Canada reduced their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. UBS Group upped their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Finally, Piper Sandler dropped their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $5.66 during trading hours on Thursday, hitting $560.28. The company's stock had a trading volume of 1,793,655 shares, compared to its average volume of 1,637,751. The company has a market cap of $200.81 billion, a PE ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70. The business has a 50 day moving average price of $502.26 and a two-hundred day moving average price of $535.79. Intuitive Surgical, Inc. has a 12-month low of $386.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the firm earned $1.50 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 492 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76. Following the completion of the sale, the senior vice president now owns 4,056 shares in the company, valued at approximately $2,327,251.68. The trade was a 10.82% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,680 shares of company stock valued at $16,854,345. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.